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nfe2l2a is required for hematopoietic stem cell development
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Expression of the HSC marker genes runx1 and cmyb (green arrowheads indicate
HSCs) and the T cell marker rag in the embryonic thymus (red arrowheads) are
significantly reduced in Nfe2laMO embryos. T cells derive directly from HSCs by
4dpf and are an additional indicator of defects in HSC development.
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cdh5, efnb2a, notch1b, and gata2b are markers of the
embryonic
vasculature
and
the
hemogenic
endothelium in the developing zebrafish embryo.
Expression of cdh5, efnb2a and notch1b in Nfe2l2aMO
was similar to that of these markers in uninjected
embryos indicating that the embryonic vasculature was
normally patterned. HSCs originate from specialized
endothelial cells in the floor of the dorsal aorta called
hemogenic endothelium. These cells are marked by
the expression of the marker gene gata2b. While other
vascular markers are normal in morphant embryos,
gata2b is reduced indicating possible defects in the
development of the hemogenic endothelium, which
could explain why HSCs do not form in Nfe2l2aMO
injected embryos.

scRNAseq data generated from public dataset by Farnsworth et al., Developmental Biology, 2019: http://cells.ucsc.edu
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HSC developmental niche components are
marked by ednrab (neural crest cells) and
foxc1a and foxc1b (sclerotome cells).
Expression of these markers in Nfe2l2a
morphants is similar to that of uninjected
embryos suggesting that defects in HSC
development are not a result of defects in
the assembly of the HSC developmental
niche environment.

Results Summary
● Expression of runx1, cmyb, and rag1 show that nfe2l2a expression is required for HSC development as the
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Two-dimensional representation of single cell RNA sequencing (scRNAseq) data from zebrafish embryos at 24hpf.
Each dot represents an individual cell. Cells of the embryonic vasculature cluster together based on transcriptional
profile (red box). Nfe2l2a is expressed in clusters 213 and 88 which are cells belonging to the dorsal aorta endothelium.

Tg(fli1:EGFP)

Tg(fli:EFGP) embryos express EGFP in endothelial cells under the control of the fli1 promoter. EGFP fluorescence
highlights the arterial and venous vasculature in the zebrafish embryo. The separation between the dorsal aorta (DA,
purple line and arrowhead) and the cardinal vein (CV, orange line and arrowhead) is clear in uninjected embryos. Nfe2l2a
morphants embryos show arterial-venous malformations (red arrowhead), blood vessel fusion (blue arrowhead) and
blood vessel dilation (yellow arrowhead). These results indicated morphological defects in embryonic blood vessel
development in Nfe2l2a morphant embryos despite normal expression of vascular and arterial marker genes.
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Hematopoietic Stem Cells (HSCs) are the self-renewing population of cells that generate all erythrocytes and leukocytes
over the lifetime of a vertebrate organism. HSCs are also the therapeutic units of curative bone marrow transplants used in
the treatment of blood malignancies and in gene therapy for genetic blood disorders. In all vertebrate embryos, HSCs
originate from the floor of the embryonic dorsal aorta during the endothelial to hematopoietic transition. Nascent HSCs will
bud into the blood vessel and be carried to maturation sites by the embryonic blood flow. Despite the curative potential of
HSC transplants in blood disorders, this approach is limited by low numbers of immunologically compatible HSCs for
transplantation. A major objective is to generate unlimited numbers of patient matched HSCs from patient derived induced
pluripotent stem cells (iPSCs) to alleviate this challenge to therapy, however it has not yet been possible to generate HSCs
from iPSCs. This is likely because key developmental signals remain unknown. This makes the study of HSC development
in the vertebrate embryo a key area of biomedical study. Previous work has suggested glucose metabolism generates
reactive oxygen species (ROS) which are needed for HSC development. Nfe2l2a is a transcription factor and master
regulator of the cellular antioxidant response and is activated by increased levels of ROS in the cell. Nfe2l2a has been
previously indicated as a regulator of ROS mediated cytokine signaling in adult HSCs. Additionally, nfe2l2a is expressed in
the embryonic vasculature of zebrafish embryos, which is the origin of HSCs. We sought to determine whether nfe2l2a is
required for the development of HSCs in the zebrafish embryo. The zebrafish pre-clinical animal model serves as an
appropriate model due to evolutionary conservation of hematopoiesis between the zebrafish and humans. We examined the
expression of the conserved hematopoietic markers runx1, cmyb, and rag1 in embryos injected with an antisense
morpholino oligonucleotide which disrupts nfe2l2a mRNA translation. We observed a significant reduction in the expression
of these markers, indicative of impaired HSC development. Since normal patterning of the embryonic dorsal aorta is required
for HSC development, the embryonic vasculature of nfe2l2a morphants was also examined for expression of key marker
genes, which indicated normal patterning of these tissues. Interestingly, examination of fli1:EGFP transgenic embryos
injected with nfe2l2a morpholino revealed arterio-venous malformations which are indicative of defects in the segregation of
the dorsal aorta and cardinal vein. Overall, our work has revealed that nfe2l2a activity is required for the development of
HSCs in the zebrafish embryo, possibly by controlling segregation of the dorsal aorta and cardinal vein blood vessels during
development. Future experiments will be aimed at determining how nfe2l2a regulates this process.

Vascular morphology appears disrupted in nfe2l2a knockdown
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knockdown embryos lack expression of these key marker genes.
Vascular patterning, however, appears normal in Nfe2l2aMO knockdown embryos based on the expression
of cdh5, efnb2a and notch1b marker genes.
Development of the hemogenic endothelium might be disrupted in Nfe2l2a morphant embryos as indicated
by a reduction in the expression of gata2b in the dorsal aorta.
Despite normal vascular patterning, examination of fli1:EGFP transgenic embryos has revealed defects in
vascular morphology in Nfe2l2a morphants indicating aspects of vascular development is perturbed.
HSC developmental niche components appear to assembly normally in Nfe2l2a morphant embryos.
Nfe2l2a could be required for normal development of the hemogenic endothelium and thus HSCs.
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